4.5 Review

Recruiting underserved populations to dermatologic research: a systematic review

Journal

INTERNATIONAL JOURNAL OF DERMATOLOGY
Volume 50, Issue 4, Pages 385-395

Publisher

WILEY
DOI: 10.1111/j.1365-4632.2010.04813.x

Keywords

-

Categories

Funding

  1. NIH [R21 AI 70687]
  2. Galderma Laboratories, L.P.

Ask authors/readers for more resources

Recruitment of participants to dermatologic research studies can be challenging, particularly with historically underserved populations. Recruitment of these groups is essential to ethical, valid, and useful dermatologic research. This article discusses findings from a review of 78 studies that examined factors influencing participation in health research studies with an emphasis on underserved populations, particularly women and ethnic minorities. The most commonly encountered barriers to research participation are mistrust of research, lack of access to research programs, and culturally incompetent research design. Motives to participate in research include receipt of benefit from participation, perceived opportunities to help others, and culturally competent research design. Practical methods for addressing barriers and enhancing research participation include culturally competent research design, community-based recruitment, and easily understandable informed consent. These factors should be considered when recruiting subjects for dermatologic research, especially when recruitment of underserved populations is desired. In addition, the literature demonstrates a paucity of research among rural residents, infants, and children, as well as within clinical dermatologic research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Developmental

Regulatory Focus, Family--Work Interface, and Adult Life Success

Aosai Liu, Srikant Manchiraju, Nicholas J. Beutell, Neena Gopalan, Wendy Middlemiss, Sapna Srivastava, Joseph G. Grzywacz

Summary: This study examined the applicability of Regulatory Focus Theory (RFT) in a sample of married immigrants living and working in the United States. The results supported the core hypotheses of RFT, indicating that a promotion-focused orientation is more strongly associated with adults' life success compared to a prevention-focused orientation. In addition, the study found that family-to-work enrichment is related to a promotion-focused orientation, while family-to-work conflict is related to a prevention-focused orientation.

JOURNAL OF ADULT DEVELOPMENT (2023)

Review Pharmacology & Pharmacy

A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis

Jessica N. Pixley, Taylor Schaetzle, Steven R. Feldman

Summary: This article reviews clinical trials on the efficacy, safety, and clinical application of once-daily roflumilast 0.3% cream for plaque psoriasis treatment. The results show that roflumilast is effective and safe, and it has potential as a nonsteroidal alternative to topical corticosteroids.

ANNALS OF PHARMACOTHERAPY (2023)

Article Infectious Diseases

Prescribing Trends for Acne Vulgaris Visits in the United States

Patrick O. Perche, Gabrielle M. Peck, Lillian Robinson, Ayman Grada, Alan B. Fleischer Jr, Steven R. Feldman

Summary: Acne vulgaris is a common reason for patients to seek care from dermatologists in the US, but referring providers may be hesitant to prescribe acne treatments or certain medications. A study analyzed prescription rates for acne therapies from 1993 to 2016 and found that younger patients and privately insured patients were more likely to receive prescription treatments. Dermatologists were more likely to recommend prescription medications compared to family medicine and pediatric providers. Oral minocycline and oral doxycycline were the most commonly prescribed antibiotics, while benzoyl peroxide was the most utilized and recommended over-the-counter drug for acne.

ANTIBIOTICS-BASEL (2023)

Editorial Material Dermatology

Commentary on Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology

Heli Patel, Steven R. Feldman

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2023)

Review Pharmacology & Pharmacy

Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Christopher Alihosseini, Hannah Kopelman, Mallory Zaino, Steven R. Feldman

Summary: This study reviewed the safety and efficacy of avacopan for the treatment of ANCA-associated vasculitis. The results showed that avacopan can improve remission rates and reduce side effects caused by steroid use. Therefore, avacopan may be a new option for the treatment of ANCA-associated vasculitis.

ANNALS OF PHARMACOTHERAPY (2023)

Review Pharmacology & Pharmacy

A Review of Topical Tapinarof for the Treatment of Plaque Psoriasis

Meghan C. Grossmann, Jessica N. Pixley, Steven R. Feldman

Summary: This article reviews the efficacy and safety of 1% tapinarof cream for plaque psoriasis. The results of two 12-week phase III clinical trials showed that around 35.4% to 40.2% of patients achieved clear or almost clear disease severity at week 12. In the 40-week, open-label extension trial, 40.9% of patients achieved a Physician's Global Assessment (PGA) score of 0 at least once. Tapinarof may be an effective and safe topical treatment for mild to severe plaque psoriasis.

ANNALS OF PHARMACOTHERAPY (2023)

Letter Dermatology

Regional Variation in Cardiovascular Risk Factor Screening by Dermatologists for Psoriasis Patients in the United States

William B. Song, Gabrielle M. Peck, Aakriti Neopaney, Daniel B. Shin, Alan B. Fleischer Jr, Steven R. Feldman, Joel M. Gelfand, Hideki Mochizuki, James T. Elder, Yukinori Okada

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Review Pharmacology & Pharmacy

A Review of Topical Sirolimus for the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex

Diem-Phuong D. Dao, Jessica N. Pixley, Zeynep M. Akkurt, Steven R. Feldman

Summary: This article evaluates the effectiveness, safety, pharmacology, and clinical applications of topical sirolimus 0.2% gel for treating tuberous sclerosis complex (TSC)-associated facial angiofibromas. The gel showed improvement in tumor size and redness without any serious adverse events. It is considered a safe and effective noninvasive alternative to surgical procedures for TSC-related angiofibromas.

ANNALS OF PHARMACOTHERAPY (2023)

Letter Dermatology

Facial analysis technologies do not appear to increase sunscreen use

Jessica N. Pixley, Mallory L. Zaino, Christina L. Kontzias, Rachel E. Tao, Steven R. Feldman

Summary: This study aimed to determine if showing patients their facial characteristics using an AI application would increase their use of sunscreen. The findings showed a decrease in self-reported sunscreen usage after the study, while skincare product usage remained unchanged.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2023)

Letter Dermatology

Patients with vulvar lichen sclerosus prioritize education on disease etiology, triggers and treatment

Emily A. Parks, Mallory L. Zaino, Jessica N. Pixley, Vani Mangalam Subramanian, Deepak Sirdeshmukh, Steven R. Feldman, Rita O. Pichardo

JOURNAL OF DERMATOLOGICAL TREATMENT (2023)

Article Dermatology

Management of Pediatric Psoriasis: A US Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS)

Rachel E. Tao, Jessica N. Pixley, Phillip G. Holovach, Alan B. Fleischer Jr, Steven R. Feldman

Summary: Off-label treatments are commonly used for pediatric psoriasis, with topical treatments, especially unapproved tacrolimus, being the most common approach. This may indicate a hesitance to use corticosteroids in children.

DERMATOLOGY AND THERAPY (2023)

Review Infectious Diseases

Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy

Rachel E. Tao, Stuti Prajapati, Jessica N. Pixley, Ayman Grada, Steven R. Feldman

Summary: Tetracycline-class drugs are commonly used in dermatology for treating skin diseases. This study reviewed the available evidence on whether taking these drugs with food affects their absorption and clinical efficacy. The study found that co-administration with food decreased systemic absorption of tetracycline, while the impact on doxycycline and minocycline varied. Oral sarecycline showed decreased absorption with food. Only sarecycline demonstrated limited or no impact of food intake on clinical efficacy. The study suggested considering patient adherence when choosing to take doxycycline, minocycline, and sarecycline with food.

ANTIBIOTICS-BASEL (2023)

Review Biochemistry & Molecular Biology

The Genetic Susceptibility to Psoriasis and the Relationship of Linked Genes to Our Treatment Options

Heli A. A. Patel, Rishab R. R. Revankar, Sofia T. T. Pedroza, Shaveonte Graham, Steven R. R. Feldman

Summary: Understanding the genetic factors in psoriasis can help improve targeted treatment strategies. This review discusses the genes associated with psoriasis pathogenesis and their connection to available treatment options. Searching various databases, relevant genetic markers and treatments were identified. Gene variants involved in inflammatory pathways, such as interleukins and interferons, are commonly implicated in psoriasis. Some treatments, like IL23 and TYK2 inhibitors, target genes associated with psoriasis. Multiple genes are involved in psoriasis pathogenesis, providing potential avenues for developing new treatment strategies and improving outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Dermatology

Understanding the Medical Dictionary for Regulatory Activities (MedDRA) reporting of herpes simplex virus (HSV) adverse events in atopic dermatitis clinical trials

Rachel E. Tao, Jessica N. Pixley, Christina L. Kontzias, Steven R. Feldman

Summary: Drug efficacy is best evaluated through randomized, controlled, double-blind clinical trials, while safety assessment is more challenging. The Medical Dictionary for Regulatory Activities (MedDRA) is used to track and categorize adverse events (AE) during clinical trials. This study reviewed recent clinical trials on atopic dermatitis to demonstrate the importance of understanding MedDRA in evaluating adverse events related to herpes simplex virus (HSV) infection.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2023)

Review Dermatology

Quality of Life Assessments Utilized in Vitiligo Clinical Trials

Gaurav N. Pathak, Rithi J. Chandy, Vidisha Naini, Steven R. Feldman, Babar K. Rao

Summary: This study analyzed clinical trials on vitiligo and found that less than half of the trials used quality of life (QoL) assessments, with DLQI and CDLQI being the commonly used tools. As the number of trials increases, vitiligo-specific questionnaires may be more suitable for evaluating unique vitiligo-related concerns.

DERMATOLOGIC THERAPY (2023)

No Data Available